» Articles » PMID: 2736330

In Vitro Differentiated HT 29-D4 Clonal Cell Line Generates Leakproof and Electrically Active Monolayers when Cultured in Porous-bottom Culture Dishes

Overview
Journal Biol Cell
Specialty Cell Biology
Date 1989 Jan 1
PMID 2736330
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

HT 29-D4 is a clonal cell line, derived from the human colon adenocarcinoma cell line HT 29, which can be induced to differentiate into enterocyte-like cells by replacing glucose with galactose in the culture medium (Fantini et al. [1986], J. Cell Sci. 83, 235-249). Both undifferentiated and differentiated HT 29-D4 cells have been successfully grown to confluency in Costar Transwell permeable chambers. Only HT 29-D4 cells grown in glucose-free, galactose-containing medium were able to form leakproof monolayers, as demonstrated by their ability to prevent diffusion of serum proteins. These monolayers consist of highly polarized epithelial-like cells with a well organized apical brush border. Transepithelial electrical parameters have been measured under sterile conditions for both types of monolayer. Only HT 29-D4 monolayers cultured in glucose-free, galactose-containing medium were electrically active, with a transepithelial resistance R = 172 +/- 46 omega.cm2, a potential difference PD = 0.35 +/- 0.05 mV, apical negative and a short-circuit current Isc = 2.0 +/- 0.4 microA.cm-2. Apical addition of amphotericin B induced a rapid and considerable increase in Isc and PD, which was abolished by basal ouabain. In contrast, HT 29-D4 cells grown in glucose-containing medium did not generate any potential difference (PD = 0 mV) and their resistance was very low (R = 34.1 +/- 0.9 omega.cm2). It is concluded from these studies that HT 29-D4 cells grown in glucose-free, galactose-containing medium acquire functional characteristics of epithelia, compared to HT 29-D4 cells grown in glucose-containing medium.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery.

Di Scala C, Armstrong N, Chahinian H, Chabriere E, Fantini J, Yahi N Int J Mol Sci. 2022; 23(21).

PMID: 36362170 PMC: 9654333. DOI: 10.3390/ijms232113383.


Polarized distribution of gamma interferon-stimulated MHC antigens and transferrin receptors in a clonal cell line isolated from Fisher rat thyroid (FRT cells).

Boudier J, Fantini J, Gerard C, Verrier B Cell Tissue Res. 1993; 272(1):23-31.

PMID: 8481954 DOI: 10.1007/BF00323567.


Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-6 in differentiated human colon cancer cells.

Remacle-Bonnet M, Garrouste F, el Atiq F, Marvaldi J, Pommier G J Clin Invest. 1995; 96(1):192-200.

PMID: 7542277 PMC: 185188. DOI: 10.1172/JCI118020.


Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.

Fantini J, Yahi N, Chermann J Proc Natl Acad Sci U S A. 1991; 88(20):9297-301.

PMID: 1718004 PMC: 52701. DOI: 10.1073/pnas.88.20.9297.


Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells.

Yahi N, Baghdiguian S, Moreau H, Fantini J J Virol. 1992; 66(8):4848-54.

PMID: 1378511 PMC: 241313. DOI: 10.1128/JVI.66.8.4848-4854.1992.